Literature DB >> 26605929

Treatment of Tuberculosis.

C Robert Horsburgh, Clifton E Barry, Christoph Lange.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26605929     DOI: 10.1056/NEJMra1413919

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  103 in total

1.  Evolution of Rifampin Resistance in Escherichia coli and Mycobacterium smegmatis Due to Substandard Drugs.

Authors:  Zohar B Weinstein; Muhammad H Zaman
Journal:  Antimicrob Agents Chemother       Date:  2018-12-21       Impact factor: 5.191

Review 2.  Primary ethambutol resistance among Iranian pulmonary tuberculosis patients: a systematic review.

Authors:  Mohammad Javad Nasiri; Abbas Ali Imani Fooladi; Hossein Dabiri; Ali Pormohammad; Alireza Salimi Chirani; Masoud Dadashi; Hamidreza Houri; Mohsen Heidary; Mohammad Mehdi Feizabadi
Journal:  Ther Adv Infect Dis       Date:  2016-08-10

3.  Drug susceptibility testing and mortality in patients treated for tuberculosis in high-burden countries: a multicentre cohort study.

Authors:  Kathrin Zürcher; Marie Ballif; Lukas Fenner; Sonia Borrell; Peter M Keller; Joachim Gnokoro; Olivier Marcy; Marcel Yotebieng; Lameck Diero; E Jane Carter; Neesha Rockwood; Robert J Wilkinson; Helen Cox; Nicholas Ezati; Alash'le G Abimiku; Jimena Collantes; Anchalee Avihingsanon; Kamon Kawkitinarong; Miriam Reinhard; Rico Hömke; Robin Huebner; Sebastien Gagneux; Erik C Böttger; Matthias Egger
Journal:  Lancet Infect Dis       Date:  2019-02-08       Impact factor: 25.071

4.  Surgical interventions for pulmonary tuberculosis in Mumbai, India: surgical outcomes and programmatic challenges.

Authors:  S Shirodkar; L Anande; A Dalal; C Desai; G Corrêa; M Das; C Laxmeshwar; H Mansoor; D Remartinez; M Trelles; P Isaakidis
Journal:  Public Health Action       Date:  2016-09-21

Review 5.  Tuberculous pleural effusion.

Authors:  Kan Zhai; Yong Lu; Huan-Zhong Shi
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

6.  The genotypic study of Mycobacterium tuberculosis complex resistant to isoniazid: Galicia, Spain (2008-2013).

Authors:  M L Pérez Del Molino; G Barbeito-Castiñeiras; B Mejuto; P Alonso; A Fernández; G González-Mediero
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-09-01       Impact factor: 3.267

Review 7.  New Approaches and Therapeutic Options for Mycobacterium tuberculosis in a Dormant State.

Authors:  Santiago Caño-Muñiz; Richard Anthony; Stefan Niemann; Jan-Willem C Alffenaar
Journal:  Clin Microbiol Rev       Date:  2017-11-29       Impact factor: 26.132

8.  Surprising pathological and clinical manifestations of miliary tuberculosis.

Authors:  Kamonkiat Wirunsawanya; Dennis Thomas Bolger
Journal:  BMJ Case Rep       Date:  2018-05-12

9.  Spirocycle MmpL3 Inhibitors with Improved hERG and Cytotoxicity Profiles as Inhibitors of Mycobacterium tuberculosis Growth.

Authors:  Peter C Ray; Margaret Huggett; Penelope A Turner; Malcolm Taylor; Laura A T Cleghorn; Julie Early; Anuradha Kumar; Shilah A Bonnett; Lindsay Flint; Douglas Joerss; James Johnson; Aaron Korkegian; Steven Mullen; Abraham L Moure; Susan H Davis; Dinakaran Murugesan; Michael Mathieson; Nicola Caldwell; Curtis A Engelhart; Dirk Schnappinger; Ola Epemolu; Fabio Zuccotto; Jennifer Riley; Paul Scullion; Laste Stojanovski; Lisa Massoudi; Gregory T Robertson; Anne J Lenaerts; Gail Freiberg; Dale J Kempf; Thierry Masquelin; Philip A Hipskind; Joshua Odingo; Kevin D Read; Simon R Green; Paul G Wyatt; Tanya Parish
Journal:  ACS Omega       Date:  2021-01-13

10.  [Tuberculosis].

Authors:  Christoph Lange; Barbara Kalsdorf; Florian P Maurer; Jan Heyckendorf
Journal:  Internist (Berl)       Date:  2019-11       Impact factor: 0.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.